3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| NVP-DKY709 | 2291360-73-9 | |
| EG-011 | 2377113-41-0 | |
| Nelfinavir | 甲磺酸萘非那韦 | 159989-64-7 |
| SR144528 | 化合物 SR144528 | 192703-06-3 |
| 89738362-9 | AST-1306 | 897383-62-9 |
| SLx-2119 | 2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 | 911417-87-3 |
| 4SC-202 | 4SC-202(盐的形式) | 1186222-89-8 |
| GI 254023X | (ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲酰基羟基氨基)乙基]苯戊酰胺 | 260264-93-5 |
| TIC-10 Analogue | TIC-10 | 41276-02-2 |
| SBI0206965 | SBI0206965; SBI-0206965; SBI 0206965. | 1884220-36-3 |
| ON1231320 | CS-2589 | 1312471-39-8 |
| NCT-503 | NCT503 | 1916571-90-8 |
| Emixustat Hydrochloride | 特戈拉赞 | 942195-55-3 |
| Dapansutrile | 3-甲磺酰基丙腈 | 54863-37-5 |
| Sage217 | CS-2797 | 1632051-40-1 |
| Lazertinib | YH-25448 | 1903008-80-9 |
| AZD-7648 | 2230820-11-6 | |
| ASP-2905) | 化合物ASP-2905 | 792184-90-8 |
| PEAQX | 化合物PEAQX | 459836-30-7 |
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- | 1801344-14-8 | |
| DPTIP | 351353-48-5 | |
| Anagrelide Hydrochloride | 盐酸阿那格雷 | 58579-51-4 |
| UCB-9260 | 1515888-53-5 | |
| 4-Hydroxy-3-methoxyphenylglycol sulfate potassium salt | 4-羟基-3-甲氧基苯基乙二醇-4-硫酸钾盐 | 71324-20-4 |
| 1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2-methyl[1,1-biphenyl]-4-yl)- | AG-636 | 1623416-31-8 |
| Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | 2201056-66-6 | |
| NCT-58 | 化合物NCT-58 | 2411429-33-7 |
| SRI-37330 HCl | SRI-37330 HYDROCHLORIDE; SRI37330 HYDROCHLORIDE; SRI 37330 HYDROCHLORIDE; SRI-37330 HCL; SRI37330 HCL; SRI 37330 HCL; | 2322245-49-6 |
| Britanin | 旋覆花内酯 | 33627-28-0 |
| 9-Ethyl-9H-carbazole-3,6-dicarboxaldehyde | N-乙基咔唑-3,6-二甲醛 | 70207-46-4 |
| URMC-099 | 1229582-33-5 | |
| EDO-S101 | 1236199-60-2 | |
| GSK484 | CS-2265 | 1652591-81-5 |
| GSK864 | 1816331-66-4 | 1816331-66-4 |
| THAL-SNS-032 | 2139287-33-3 | |
| L755507 | L755,507 | 159182-43-1 |
| oxyphenisatinedi(acetate) | 双醋酚丁 | 115-33-3 |
| HS-276 | 化合物 HS-276 | 2767422-72-8 |
| tetrabutylazanium,nitrite | 四丁基亚硝酸铵 | 26501-54-2 |
| SB265610 | 化合物SB-265610 | 211096-49-0 |
| MK-2206 2HCl | 1032350-13-2 | |
| BNC-105 | BNC105 | 945771-74-4 |
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide | BET抑制剂 | 1380087-89-7 |
| Gentamicin | 庆大霉素 | 1403-66-3 |
| Gigantol | 石斛酚 | 83088-28-2 |
| VH298 | 2097381-85-4 | |
| LSZ-102 | CS-2791 | 2135600-76-7 |
| ACBI1 | 2375564-55-7 | |
| 1H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-[4-(2S)-2-morpholinylphenyl]- | 化合物RALMITARONT | 2133417-13-5 |
| SHP2-IN-6 | JAB-3068 | 2169223-48-5 |
| Propanamide, N,N-dimethyl-2-[[4-(2-methylphenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]- | 化合物LDC195943(IMT1) | 2304621-31-4 |
| GPR183 | 化合物GPR183 | 1241280-25-0 |
| 6K465 | 2702965-27-1 | |
| EN1441 | 2196448-47-0 | |
| NC318 | ||
| tafasitamab | 1422527-84-1 | |
| tiragolumab | 1918185-84-8 | |
| FAP targeting peptide for FXX489 | 3076328-74-7 | |
| rozanolixizumab | 1584645-37-3 | |
| ABT-102 | 808756-71-0 | |
| GDC-2992 | 2753651-10-2 | |
| PROTAC BRD4 Degrader-13 | 2417370-71-7 | |
| Tamoxifen Impurity G | 68047-07-4 | |
| opiranserin hydrochloride | 1440796-75-7 | |
| (Rac)-AF710B | 1235733-73-9 | |
| RO7567132 | ||
| GSK4418959/IDE275 | 3064599-36-3 | |
| M0324 | ||
| vorsetuzumab | 1165740-62-4 | |
| varlilumab | 1393344-72-3 | |
| codrituzumab | 1365267-33-9 | |
| AZD0022 | 2958627-18-2 | |
| Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | 2857037-70-6 | |
| 2-氯-4-氟烟酸甲酯 | 1805523-13-0 | |
| PF-06372222 | 1407592-99-7 | |
| HG106 | ACETAMIDE, 2-CHLORO-N-[2-(4-METHOXYPHENYL)-2H-BENZOTRIAZOL-5-YL]- | 928712-10-1 |
| Quiflapon | 喹夫拉朋 | 136668-42-3 |
| Werner syndrome RecQ helicase-IN-1 | [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM | 2869954-34-5 |
| Batatasin IV | 山药素IV | 60347-67-3 |
| 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one | 883065-90-5 | |
| W146 hydrate | W146HYDRATE | 909725-61-7 |
| AZD-4818 | CCR1 antagonist | 1003566-93-5 |
| 3-broMopyrido | 3-溴吡啶并[2,3-D]哒嗪-8(7H)-酮 | 909186-02-3 |
| TAS-115 | 1190836-34-0 | 1190836-34-0 |
| Propionyl-L-carnitine solution | 丙酰左旋肉碱盐酸盐 | 20064-19-1 |
| NSC 146109 | NSC 146109 (HYDROCHLORIDE);XI-011 | 59474-01-0 |
| 9-ING-41 | 1034895-42-5 | |
| PF06700841 | CS-2861 | 1883299-62-4 |
| AB680 | AB-680 | 2105904-82-1 |
| AZD-5672 | 780750-65-4 | |
| Bepridil hydrochloride | 盐酸苄普地尔 | 74764-40-2 |
| Colchicoside | 秋水仙碱EP杂质D | 477-29-2 |
| BI-749327 | 2361241-23-6 | |
| TPX-0022 | CSF1R-IN-2 | 2271119-26-5 |
| Nω-Hydroxy-nor-L-Arginine Dihydrochloride | NΩ-羟基或- L -精氨酸盐酸盐 | 291758-32-2 |
| α-Amyrin | alpha-香树精 | 638-95-9 |
| ULK-101 | 2-Thiophenecarboxamide, N-[(1S)-1-cyclopropyl-2,2,2-trifluoroethyl]-4-[6-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]- | 2443816-45-1 |
| [2,3-Bipyridine]-5-carboxamide, N-[4-[2-amino-5-[4-[(2R)-1,4-dioxan-2-ylmethoxy]-3-methoxyphenyl]-3-pyridinyl]-3-fluorophenyl]-1,4-dihydro-5-methyl-4-oxo-1-[(tetrahydro-2H-pyran-4-yl)methyl]- | 化合物DS-1205 | 1855860-24-0 |
| 3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropyl acetate | 2641451-61-6 | |
| Mito-TRFS |
联系方式
